We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » OGD ‘Attack’ Team Reviewing Supplements for Shorted Drugs
OGD ‘Attack’ Team Reviewing Supplements for Shorted Drugs
June 18, 2013
In an effort to reduce the backlog of ANDA supplements, a review team within CDER’s Office of Generic Drugs (OGD) this month will start reviewing all backlogged supplements for drugs currently on the FDA’s shortages list.